Facial Hemangiomas May Signal PHACE

• by Andrea Surnit

• April 14, 2026

Botulinum Toxin Evaluated in Digital Ischemia

Individual-level meta-analysis examines response, dosing, and safety across ischemic etiologies

• by Kathryn Wighton

• April 3, 2026

• 3 min

Summary of Research: Apremilast Improves Skin Outcomes in Pediatric Plaque Psoriasis of Shorter Disease Duration: 52-Week Results from the SPROUT Phase 3 Trial

• by Richard G. Langley, Lisa Arkin, Loretta Fiorillo, Lawrence F. Eichenfield, Mark Lebwohl, Bruce Strober, Michael Sticherling, Lisa Swanson, Georgios Kokolakis, Siddharth Chaudhari, Cynthia Deignan, Zuoshun Zhang, Amy S. Paller

• May 14, 2026

FDA Clears Self-Administered Lupus Therapy

Once-weekly autoinjector approval was based on Phase 3 data, with safety consistent with intravenous administration.

• by Kathryn Wighton

• April 28, 2026

• 2 min